Resistance of SARS-CoV-2 omicron subvariant BA.4.6 to antibody neutralisation

被引：4
|
作者：
Wang, Qian [1 ]
Li, Zhiteng [1 ]
Ho, Jerren [1 ]
Guo, Yicheng [1 ]
Yeh, Andre Yanchen [3 ]
Mohri, Hiroshi [1 ]
Liu, Michael [1 ]
Wang, Maple [1 ]
Yu, Jian [1 ]
Shah, Jayesh G. [2 ]
Chang, Jennifer Y. [2 ]
Herbas, Favio [2 ]
Yin, Michael T. [2 ]
Sobieszczyk, Magdalena E. [2 ]
Sheng, Zizhang [1 ]
Liu, Lihong [1 ]
Ho, David [1 ]
机构：
[1] Columbia Univ, Vagelos Coll Phys & Surg, Aaron Diamond AIDS Res Ctr, New York, NY 10032 USA
[2] Columbia Univ, Vagelos Coll Phys & Surg, Dept Med, Div Infect Dis, New York, NY USA
[3] Natl Taiwan Univ, Sch Med, Taipei, Taiwan
来源：
LANCET INFECTIOUS DISEASES | 2022年 / 22卷 / 12期
关键词：
D O I：
10.1016/S1473-3099(22)00688-0
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：1666 / 1668
页数：3
相关论文
共 50 条
  • [1] Antigenic characterization of SARS-CoV-2 Omicron subvariant BA.4.6
    Dijokaite-Guraliuc, Aiste
    Das, Raksha
    Nutalai, Rungtiwa
    Zhou, Daming
    Mentzer, Alexander J.
    Liu, Chang
    Supasa, Piyada
    Dunachie, Susanna J.
    Lambe, Teresa
    Fry, Elizabeth E.
    Mongkolsapaya, Juthathip
    Ren, Jingshan
    Huo, Jiandong
    Stuart, David I.
    Screaton, Gavin R.
    CELL DISCOVERY, 2022, 8 (01)
  • [2] Neutralization Escape by SARS-CoV-2 Omicron Subvariant BA.4.6
    Hachmann, Nicole P.
    Miller, Jessica
    Collier, Ai-ris Y.
    Barouch, Dan H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (20): : 1904 - 1906
  • [3] Antigenic characterization of SARS-CoV-2 Omicron subvariant BA.4.6
    Aiste Dijokaite-Guraliuc
    Raksha Das
    Rungtiwa Nutalai
    Daming Zhou
    Alexander J. Mentzer
    Chang Liu
    Piyada Supasa
    Susanna J. Dunachie
    Teresa Lambe
    Elizabeth E. Fry
    Juthathip Mongkolsapaya
    Jingshan Ren
    Jiandong Huo
    David I. Stuart
    Gavin R. Screaton
    Cell Discovery, 8
  • [4] Antiviral Agents against Omicron Subvariant BA.4.6 In Vitro
    Walker, Jill
    Schnell, Gretja
    Kerr, William
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (05):
  • [5] In Vitro Efficacy of Antiviral Agents against Omicron Subvariant BA.4.6
    Takashita, Emi
    Yamayoshi, Seiya
    Halfmann, Peter
    Wilson, Nancy
    Ries, Hunter
    Richardson, Alex
    Bobholz, Max
    Vuyk, William
    Maddox, Robert
    Baker, David A.
    Friedrich, Thomas C.
    O'Connor, David H.
    Uraki, Ryuta
    Ito, Mutsumi
    Sakai-Tagawa, Yuko
    Adachi, Eisuke
    Saito, Makoto
    Koga, Michiko
    Tsutsumi, Takeya
    Iwatsuki-Horimoto, Kiyoko
    Kiso, Maki
    Yotsuyanagi, Hiroshi
    Watanabe, Shinji
    Hasegawa, Hideki
    Imai, Masaki
    Kawaoka, Yoshihiro
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (22): : 2094 - 2097
  • [6] Antiviral Agents against Omicron Subvariant BA.4.6 In Vitro reply
    Uraki, Ryuta
    Imai, Masaki
    Kawaoka, Yoshihiro
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (05):
  • [7] Neutralization of SARS-CoV-2 Omicron subvariant BA.2.87.1
    Lasrado, Ninaad
    Rossler, Annika
    Rowe, Marjorie
    Collier, Ai-ris Y.
    Barouch, Dan H.
    VACCINE, 2024, 42 (09) : 2117 - 2121
  • [8] The omicron BA.2.86 subvariant as a new serotype of SARS-CoV-2
    Du, Pei
    Wu, Chunli
    Hu, Shixiong
    Fan, Rui
    Gao, George Fu
    Wang, Qihui
    LANCET MICROBE, 2024, 5 (06): : e516 - e516
  • [9] Antigenic characterization of the SARS-CoV-2 Omicron subvariant BA.2.75
    Wang, Qian
    Iketani, Sho
    Li, Zhiteng
    Guo, Yicheng
    Yeh, Andre Yanchen
    Liu, Michael
    Yu, Jian
    Sheng, Zizhang
    Huang, Yaoxing
    Liu, Lihong
    Ho, David D.
    CELL HOST & MICROBE, 2022, 30 (09) : 1512 - +
  • [10] Serum neutralisation of the SARS-CoV-2 omicron sublineage BA.2
    Chen, Lin-Lei
    Chu, Allen Wing-Ho
    Zhang, Ricky Rui-Qi
    Hung, Ivan Fan-Ngai
    To, Kelvin Kai-Wang
    LANCET MICROBE, 2022, 3 (06): : E404 - E404
12345